The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia ... Ozempic Linked to Significant Reduction in Dementia—Study. Published Jun 25, 2025 ...

The case for Ozempic as a dementia buster is building. Research published this week has found that GLP-1 drugs are associated with a lower risk of dementia in people with type 2 diabetes.

Ozempic and similar novel ... of randomized clinical trials found that glucose lowering with GLP-1RAs was associated with a statistically significant reduction in all-cause dementia," the ...

The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, ... there may be additional dementia risk reduction for semaglutide, ...

Does Ozempic also hold the secret to a cure for depression and dementia? As Wes Streeting suggests new weight-loss jabs could be given to unemployed people to help them get back into work, doctors ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

“According to the latest figures released by the NHS, dementia diagnosis is at a record high in England. ... Pharmacist cautions against self-medicating with ozempic for dementia risk reduction.

Drugs like Ozempic and Wegovy could slash risk of dementia. ... Meanwhile, researchers in Ireland suggested GLP-1RAs are “associated with a statistically significant reduction in dementia”.

GLP-1s – weight-loss drugs like Ozempic, Wegovy, Zepbound and Mounjaro – also may help treat a litany of other health conditions. New research shows they may help reduce the risk of addiction ...

Semaglutide, the active ingredient in diabetes medications Ozempic and Wegovy, was associated with a significantly reduced risk of developing Alzheimer's disease-related dementia among patients ...